From: INDACO project: COPD and link between comorbidities, lung function and inhalation therapy
Male | Female | p | |
---|---|---|---|
Age (mean ± SD) | 73(±8) | 73(±9) | ns |
MRC (mean ± SD) | 2.29(±0.9) | 2.29(±0.9) | ns |
BMI (mean ± SD) | 27.2 (±5.1) | 26.9(±5.3) | ns |
FEV1% pred. (mean ± SD) | 52.9(±19.6) | 53.5(±17.7) | ns |
FEV1/FVC % (mean ± SD) | 59.3(±14.9) | 60.1(±16.9) | ns |
COPD exacerbations (mean ± SD) | 1.66(±1.09) | 1.48(±0.96) | 0.057 |
Charlson index (mean ± SD) | 5.1(±2.2) | 4.9(±2.2) | ns |
Comorbidities (mean ± SD) | 1.14(±1.2) | 0.9(±1.2) | 0.03 |